Analysis and formulation development services, including consultation, for intranasal and inhalation drug products
Intertek Melbourn provides high quality cGMP analytical and formulation services to the pharmaceutical, biotech and healthcare industries. Our experienced team of analysts and formulation scientists offers method development, method validation, stability studies, expertise in inhaled products and other novel delivery systems, and a wide range of product formulation and testing services. Quality is at the heart of our business and we continue to invest in the latest equipment state of the art facilities to support our clients. This is proven time and again through regular audits from clients and the regulatory bodies including many successful FDA and MHRA inspections.
With more than 20 billion DPI doses delivered and over 20 years of DPI product development experience, Capsule Delivery Solutions part of Lonza Pharma & Biotech has the expertise to solve any capsule-based dry powder inhaler delivery challenge. Capsule Delivery Solutions, is the leader in capsule-based solutions and services, proudly offering Capsugel® products. With the largest production and supply chain footprint in the industry, Capsule Delivery Solutions provides the highest quality and deepest regulatory expertise to its 2,000 pharmaceutical customers, globally.
Gateway Analytical is the innovative analytical testing laboratory that businesses around the world trust to provide solutions for their most challenging foreign particulate analysis, foreign particulate identification and materials analysis needs. Gateway’s expert scientists, specialized testing techniques and comprehensive analysis methods allow the company to deliver the fast, accurate and reliable results that customers in the pharmaceutical, materials and medical device industries demand. To learn more about Gateway Analytical and how it is making the world healthier and safer, visit www.gatewayanalytical.com.
Next Breath, a member of the AptarGroup, is a cGMP contract services organization for pharmaceutical, biotech and medical device companies that bring pulmonary, nasal, and ophthalmic drug products to market. Next Breath provides comprehensive solutions to the development processes from proof of concept to commercialization. Next Breath has led successful submissions for pulmonary and nasal drug products and devices in the US and international markets.
Would you like to list your company in this section or upgrade your existing listing? For information about supplier listing options, click here.